Q4 2024 EPS Estimates for U.S. Physical Therapy, Inc. (NYSE:USPH) Reduced by Analyst

U.S. Physical Therapy, Inc. (NYSE:USPH) – Investment analysts at Barrington Research cut their Q4 2024 earnings per share estimates for shares of U.S. Physical Therapy in a research note issued on Thursday, August 15th. Barrington Research analyst M. Petusky now expects that the company will earn $0.66 per share for the quarter, down from their prior estimate of $0.71. Barrington Research currently has a “Outperform” rating and a $108.00 target price on the stock. The consensus estimate for U.S. Physical Therapy’s current full-year earnings is $2.84 per share. Barrington Research also issued estimates for U.S. Physical Therapy’s Q4 2025 earnings at $0.75 EPS.

U.S. Physical Therapy (NYSE:USPH) last issued its earnings results on Tuesday, August 13th. The company reported $0.73 EPS for the quarter, missing the consensus estimate of $0.81 by ($0.08). The firm had revenue of $167.19 million during the quarter, compared to analyst estimates of $163.34 million. U.S. Physical Therapy had a net margin of 4.72% and a return on equity of 8.03%. U.S. Physical Therapy’s quarterly revenue was up 10.4% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $0.76 earnings per share.

Separately, StockNews.com cut U.S. Physical Therapy from a “hold” rating to a “sell” rating in a research report on Tuesday. One analyst has rated the stock with a sell rating and three have assigned a buy rating to the stock. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average target price of $112.50.

U.S. Physical Therapy Price Performance

USPH traded up $0.17 during trading on Friday, hitting $83.26. 2,088 shares of the stock traded hands, compared to its average volume of 85,221. The business has a 50 day moving average price of $93.63 and a 200 day moving average price of $99.65. The company has a debt-to-equity ratio of 0.28, a current ratio of 2.16 and a quick ratio of 2.16. U.S. Physical Therapy has a twelve month low of $78.08 and a twelve month high of $113.63. The company has a market cap of $1.25 billion, a price-to-earnings ratio of 67.59, a PEG ratio of 3.43 and a beta of 1.38.

Hedge Funds Weigh In On U.S. Physical Therapy

A number of institutional investors have recently modified their holdings of USPH. The Manufacturers Life Insurance Company increased its stake in U.S. Physical Therapy by 4.5% during the 2nd quarter. The Manufacturers Life Insurance Company now owns 7,248 shares of the company’s stock valued at $670,000 after purchasing an additional 309 shares in the last quarter. Marshall Wace LLP raised its holdings in shares of U.S. Physical Therapy by 1.1% in the 2nd quarter. Marshall Wace LLP now owns 35,392 shares of the company’s stock worth $3,271,000 after acquiring an additional 378 shares during the last quarter. Public Sector Pension Investment Board lifted its position in U.S. Physical Therapy by 7.8% in the 2nd quarter. Public Sector Pension Investment Board now owns 33,134 shares of the company’s stock valued at $3,062,000 after acquiring an additional 2,409 shares in the last quarter. Sei Investments Co. lifted its position in U.S. Physical Therapy by 0.6% in the 2nd quarter. Sei Investments Co. now owns 79,766 shares of the company’s stock valued at $7,372,000 after acquiring an additional 445 shares in the last quarter. Finally, Canada Pension Plan Investment Board purchased a new stake in shares of U.S. Physical Therapy in the second quarter worth approximately $28,000.

Insider Buying and Selling

In other U.S. Physical Therapy news, CEO Christopher J. Reading sold 2,900 shares of the company’s stock in a transaction on Thursday, May 30th. The shares were sold at an average price of $100.26, for a total transaction of $290,754.00. Following the sale, the chief executive officer now owns 95,838 shares of the company’s stock, valued at $9,608,717.88. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. In other U.S. Physical Therapy news, CEO Christopher J. Reading sold 1,100 shares of the firm’s stock in a transaction on Tuesday, May 28th. The shares were sold at an average price of $102.13, for a total value of $112,343.00. Following the completion of the sale, the chief executive officer now directly owns 99,738 shares in the company, valued at $10,186,241.94. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, CEO Christopher J. Reading sold 2,900 shares of U.S. Physical Therapy stock in a transaction on Thursday, May 30th. The shares were sold at an average price of $100.26, for a total transaction of $290,754.00. Following the completion of the sale, the chief executive officer now directly owns 95,838 shares of the company’s stock, valued at $9,608,717.88. The disclosure for this sale can be found here. 1.70% of the stock is owned by insiders.

U.S. Physical Therapy Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, September 13th. Stockholders of record on Friday, August 23rd will be given a dividend of $0.44 per share. The ex-dividend date of this dividend is Friday, August 23rd. This represents a $1.76 dividend on an annualized basis and a dividend yield of 2.11%. U.S. Physical Therapy’s dividend payout ratio (DPR) is 143.09%.

About U.S. Physical Therapy

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.